Will Olsen

Will Olsen's work experience is as follows:

- In 2021, they co-founded and became the CEO of Engage Bio, a company that develops mRNA therapies for cancer cells to produce immunotherapies.

- From 2019, Will was a Venture Partner at Pioneer Fund.

- From 2019 to 2021, they served as the Vice President of Development Operations at Rejuvenation Technologies Inc.

- From 2015 to 2020, Will was the co-founder and Chief Operating Officer of Luminist, a diagnostic platform for detecting liver disease. Luminist was later acquired by DiscernDx.

- Starting in 2013, Will worked at Biorasi, first as a Program Manager and later as a Senior Program Manager. In this role, they designed and managed clinical programs and participated in business development.

- From 2012 to 2013, they were a Research Associate at Mount Sinai Health System.

- In 2010, Will worked as an Economic Analyst Intern at SpaceWorks Enterprises, Inc.

Will Olsen has an education history that includes a Bachelor of Science (BS) degree in Economics from the University of Florida. Will also completed a Postbaccalaureate program in Premedical Sciences at Columbia University. Additionally, they attended Y Combinator, although the specific details regarding degree and field of study are not provided.